A new study has revealed how NHS waiting lists are pushing patients into risky choices - with some delaying or even avoiding ...

Oticara, an emerging pharmaceutical company advancing physician-delivered treatments for chronic rhinosinusitis (CRS), today ...

Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it has begun opening ...

Initiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease screeningWALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today ...

Redditch Medical, the UK company specialising in cleanroom contamination control solutions, has been acquired by German ...

Top‑50 global university deepens its North America and Europe collaborations to fast‑track drug discovery and health ...

Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced a ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the appointment of Bethany L. Sensenig to its Board of Directors, effective as of October 1, 2025. Ms. Sensenig was also appointed a ...

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and ...

MMS, a global, data-focused clinical research organization (CRO), is proud to announce its role in the creation and release ...

Pistoia Alliance survey finds more than three quarters of life sciences labs expect to use AI within two years, but lack of skills is a growing barrier Annual Lab of the Future Survey shows hype is ...

Igyxos Biotherapeutics, a biotechnology company dedicated to developing innovative monoclonal antibodies for infertility treatment, today announced that it has secured a EUR 5.7 million grant under ...